Gansu Provincial Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lanzhou China (1950)

Organization Overview

First Clinical Trial
2006
NCT00965471
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Affiliated Hospital of Gansu University of traditional Chinese Medicine | Gansu Cancer Hospital | Gansu Provincal Cancer Hospital | Gansu Provincial Hospital | Gansu Provincial People's Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Squamous Cell (Phase 3)

Colorectal Neoplasms (Phase 3)

Esophageal Squamous Cell Carcinoma (Phase 3)

Lung Neoplasms (Phase 3)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Sarcoma (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 30